Oncogene HER-2 in canine mammary gland carcinomas: An immunohistochemical and chromogenic in situ hybridization study

Breast Cancer Research and Treatment

Volumn 80, Issue 3, 2003, Pages 363-367

  Martín De Las Mulas, Juana ^a   Ordas J ^a   Millan Y ^a   Fernandez Soria V ^b   Ramon Y Cajal S ^b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Animal models; Canine; Carcinoma; Chromogenic in situ hybridization; Immunohistochemistry; Mammary gland; Oncogene HER 2

Indexed keywords

DIGOXIGENIN; DNA; ONCOPROTEIN; RECEPTOR PROTEIN; TYROSINE KINASE RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CHROMOGENIC IN SITU HYBDRIDIZATION; DNA PROBE; DOG; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; ONCOGENE; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAMMARY NEOPLASMS, ANIMAL; RECEPTOR, ERBB-2;

EID: 0042825448     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024929730165     Document Type: Article

References (22)

1. Groner B: Oncogene expression in mammary epithelial cells. J Cell Biochem 49: 128-136, 1992
2. Siegel PM, Dankort DL, Hardy WR, Muller WJ: Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 14: 7068-7077, 1994
3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987
4. Revillion F, Bonnetarre J, Peyrat JP: ErbB-2 oncogene in human breast cancer and its clinical significance. Eur J Cancer 34: 791-808, 1998
5. Sahin AA: Biologic and clinical significance of HER-2/neu (cerbB-2) in breast cancer. Adv Anat Pathol 7: 158-166, 2000
6. Ratcliffe N, Wells W, Wheeler K, Memoli V: The combination of in situ hybridization and immunohistochemical analysis: an evaluation of HER-2/neu expression in normal-paraffin-embedded breast carcinomas and adjacent appearing breast epithelium. Mod Pathol 10: 1247-1252, 1997
7. Isola J, Chu L, De Vries S, Matsumura K, Chew K, Ljung BM, Waldman FM: Genetic alterations in ERBB2-amplified breast carcinomas. Clin Cancer Res 5: 4140-4145, 1999
8. Hoang MP, Sahin AA, Ordonez NG, Sneige N: HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. Am J Clin Pathol 113: 852-859, 2000
9. Jimenez RE, Wallis T, Tabasczka P, Visscher DW: Determination of HER-2/neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization. Modern Pathol 13: 37-45, 2000
10. Johnson RC, Ricci Jr A, Cartun RW, Ackroyd R, Tsongalis GJ: P185HER-2 overexpression in human breast cancer using molecular and immunohistochemical methods. Cancer Invest 18: 336-342, 2000
11. Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J: Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples. Am J Pathol 157: 1467-1472, 2000
12. Zhao J, Wu R, Au A, Marquez A, Yu Y, Shi Z: Determination of HER-2 gene amplification by chromogenic in situ hybridization (CISH) in archival breast carcinoma. Mod Pathol 15: 657-665, 2002
13. Frese K: Comparative pathology of mammary tumors of domestic animals. In: Bäsler R and Hübner K (eds) Pathology of Neoplastic and Endocrine Induced Diseases of the Breast. Gustav Fischer Verlag, Stuttgart, 1986, pp 44-61
14. Nerurkar VR, Chitale AR, Jalnapurkar BV, Naik SN, Lalitha VS: Comparative pathology of canine mammary tumours. J Comp Pathol 101: 389-397, 1989
15. Withrow SJ, MacEwen EG: Small Animal Clinical Oncology. Saunders, Philadelphia, 2001, pp 455-477
16. Ahern TE, Bird RC, Bird AE, Wolfe LG: Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines. Am J Vet Res 57: 693-696, 1996
17. Rungsipipat A, Tateyama S, Yamaguchi R, Uchida K, Miyoshi N, Hayashi T: Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. J Vet Med Sci 61: 27-32, 1999
18. Misdorp W, Else RW, Hellmen E, Lipscomb TP: Histological classification of the mammary tumors of the dog and the cat. In: Armed Forces Institute of Pathology (eds) World Health Organization International Histological Classification of tumors of Domestic Animals. Second Series, Vol. VII, Washington, DC, 1999
19. Edorh A, Leroux A, N'Sossani B, Parache RM, Rihn B: Detection by immunohistochemistry of c-erbB2 oncoprotein in breast carcinomas and benign mammary lesions. Cell Mol Biol 45: 831-840, 1999
20. Ross JS, Fletcher JA: The HER-2/neu oncogene in breast cancer: prognostic factor, predicitive factor, and target for therapy. Stem Cells 16: 413-428, 1998
21. Pauletti G, Godolphin W, Press MF, Slamon DJ: Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13: 63-72, 1996
22. Murua Escobar H, Becker K, Bullerdiek J, Nolte I: The canine ERBB2 gene maps to a chromosome region frequently affected by aberrations in tumors of the dog (Canis familiaris). Cytogenet Cell Genet 94: 194-195, 2001